The Application and Validation of Serine/Threonine Phosphorylation Antibodies in Signal Transduction Research

1. Concept

Serine (Ser)/threonine (Thr) phosphorylation is a prevalent post-translational modification, accounting for over 90% of eukaryotic phosphorylation events. It involves the covalent attachment of phosphate groups to Ser/Thr side-chain hydroxyls, catalyzed by Ser/Thr kinases and reversed by phosphatases. This modification regulates protein conformation, activity, stability, or subcellular localization, serving as a core regulatory mechanism in cellular signaling pathways.

2. Research Frontiers

2.1 Key Signaling Pathways Regulated by Ser/Thr Phosphorylation

• MAPK/ERK Pathway: Governs cell growth and differentiation.
• PI3K/AKT Pathway: Mediates cell survival and metabolic regulation.
• mTOR Pathway: Controls protein synthesis and autophagy.
• CDK/Cyclin Complexes: Drive cell cycle progression.
• AMPK Pathway: Senses energy status and maintains metabolic balance.

2.2 Antibody Development and Validation Progress

• Antibody Types: Two main categories—pan-serine/threonine phosphorylation antibodies (for preliminary screening of multiple phospho-sites) and site-specific phosphorylation antibodies (targeting specific sites on proteins, e.g., Akt Ser473, GSK-3β Ser9).
• Validation Standards: Rigorous testing across platforms (Western Blot [WB], Immunohistochemistry [IHC], Immunoprecipitation [IP]) to ensure specificity, sensitivity, and cross-species reactivity (human, mouse, rat).

3. Research Significance

Ser/Thr phosphorylation antibodies are indispensable tools for decoding cellular signal transduction networks. They enable:

• Elucidation of disease mechanisms (e.g., tumorigenesis, neurodegeneration) by tracking pathway activation.
• Validation of drug targets and assessment of pharmacodynamic effects in preclinical studies.
• Discovery of novel regulatory nodes in signaling cascades, advancing basic life science research.

4. Mechanisms, Methods, and Product Applications

4.1 Regulatory Mechanism

Ser/Thr phosphorylation modulates cellular functions through structural or functional changes in target proteins:

• Conformational shifts expose active sites or binding domains.
• Alterations in protein stability affect degradation rates.
• Changes in subcellular localization redirect proteins to specific signaling compartments.

4.2 Core Research Methods

4.3 Product Empowerment by ANT BIO PTE. LTD.

ANT BIO PTE. LTD.’s STARTER brand, a leader in post-translational modification (PTM) antibodies, offers a comprehensive portfolio of Ser/Thr phosphorylation antibodies—validated for high performance in diverse research scenarios.

Key Product Examples and Roles:

1. Pan-Ser/Thr Phosphorylation Antibody (S0B6454): Recognizes multiple phospho-Ser/Thr sites, ideal for preliminary screening. Validated in WB with Calyculin A-treated HeLa cell lysates, detecting multiple phosphorylated protein bands.
2. Site-Specific Antibodies:
• Phospho-Akt (Ser473) (S0B0363): Assesses PI3K/AKT pathway activation in tumor models (breast cancer, lung cancer).
• Phospho-p44/42 MAPK (Thr202/Tyr204) (S0B0902): Monitors MAPK/ERK pathway activity in cell growth studies.
• Phospho-GSK-3β (Ser9) (S0B0518): Investigates insulin signaling and metabolic regulation.
3. Technical Advantages: Recombinant antibody technology ensures high specificity (picomolar-level KD values), batch consistency, and broad species compatibility (human, mouse, rat).

Application Cases Across Fields:

• Tumor Research: Phospho-Akt (Ser473) and Phospho-mTOR (Ser2448) antibodies reveal oncogenic pathway activation.
• Cell Cycle/Apoptosis: Phospho-Histone H3 (Ser10) labels mitotic cells; Phospho-SAPK/JNK (Thr183/Tyr185) studies stress-induced apoptosis.
• Neuroscience: Tau protein phosphorylation antibodies explore Alzheimer’s disease mechanisms; Phospho-CaMKII (Thr286) investigates synaptic plasticity.
• Metabolism: Phospho-AMPKα (Thr172) assesses cellular energy status.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering global life science advancement through three specialized sub-brands: ABSIN (general reagents, ELISA kits), STARTER (antibodies), and UA (recombinant proteins). Leveraging advanced development platforms—including recombinant rabbit/mouse monoclonal antibody generation, PTM Pan-Modification Antibody Platform, and One-Step ELISA—we deliver high-quality, compliant products certified by EU 98/79/EC, ISO9001, and ISO13485. Our mission is to partner with research institutions, pharmaceutical companies, and scientists worldwide, providing innovative reagents and solutions that accelerate discoveries in signal transduction, disease biology, and precision medicine.

6. Related Product List

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.